Global, regional, and national burden inequality of chronic kidney disease, 1990–2021: a systematic analysis for the global burden of disease study 2021
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 15, 2025
Chronic
kidney
disease
(CKD)
is
a
significant
global
health
issue,
often
linked
to
diabetes,
hypertension,
and
glomerulonephritis.
However,
aggregated
statistics
can
obscure
heterogeneity
across
subtypes,
age,
gender,
regions.
This
study
aimed
analyze
CKD
trends
from
1990
2021,
focusing
on
socio-demographic
index
(SDI),
regional
variations.
Data
were
extracted
the
Global
Burden
of
Disease
(GBD)
2021
database,
covering
prevalence,
incidence,
mortality,
disability-adjusted
life
years
(DALYs).
These
presented
as
counts
per
100,000
population
age-standardized
rates,
with
uncertainty
intervals
(UIs)
highlight
variability.
Joinpoint
regression
was
used
assess
over
30-year
period.
In
prevalence
359
million,
11.13
million
new
cases,
1.53
deaths,
44.45
DALYs-up
92,
156,
176,
114%
since
1990.
While
slightly
declined,
DALYs
increased
significantly.
burden
varied
by
region
notable
gender
disparities.
The
highlights
dramatic
rise
in
growth
aging,
emphasizing
need
for
targeted
treatment
effective
healthcare
policies.
Language: Английский
Epidemiological analysis of chronic kidney disease from 1990 to 2019 and predictions to 2030 by Bayesian age-period-cohort analysis
Renal Failure,
Journal Year:
2024,
Volume and Issue:
46(2)
Published: Sept. 19, 2024
Chronic
Kidney
Disease
(CKD)
has
emerged
as
a
significant
global
health
issue.
This
study
aimed
to
reveal
and
predict
the
epidemiological
characteristics
of
CKD.
Language: Английский
Trends and future predictions of chronic kidney disease due to diabetes mellitus type 2 attributable to dietary risks: insights based on GBD 2021 data
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 13, 2025
Background
The
2021
Global
Burden
of
Disease
(GBD)
study
shows
a
continuous
increase
in
the
burden
chronic
kidney
disease
due
to
diabetes
mellitus
type
2
(CKD-T2DM)
from
1990
2021.
This
examines
influence
dietary
risk
factors
across
various
populations
and
socioeconomic
groups.
Methods
Utilizing
GBD
data,
we
analyzed
age-standardized
CKD-T2DM
metrics—including
mortality,
disability-adjusted
life
years
(DALY),
rates
(ASR)—stratified
by
age,
gender,
region.
employs
estimated
annual
percentage
changes
(EAPC)
monitor
temporal
trends
project
future
2022
2035
using
bayesian
age-period-cohort
(BAPC)
analysis.
Results
results
indicate
that,
2021,
20.55%
mortality
23.21%
DALY
were
attributed
poor
diets,
especially
those
low
fruits
high
red
processed
meat.
Throughout
this
period,
both
associated
with
risks
increased
significantly,
most
rapid
diet
sugar-sweetened
beverages,
highlighting
considerable
impact
on
global
landscape.
Geographic
disparities
T2DM
are
evident,
significant
increases
(ASMR)
(ASDR)
observed
regions
such
as
high-income
North
America
Central
Latin
America.
Socio-demographic
index
(SDI)
is
negatively
correlated
attributable
factors.
Conclusion
Public
health
interventions
that
target
can
significantly
reduce
CKD-T2DM.
Language: Английский
Associations between the intake of single and multiple dietary vitamins and depression risk among populations with chronic kidney disease
Chunli Yu,
No information about this author
Kun Liu,
No information about this author
Weiguo Yao
No information about this author
et al.
Frontiers in Nutrition,
Journal Year:
2025,
Volume and Issue:
12
Published: Feb. 4, 2025
Background
The
effects
of
multivitamin
exposure
on
depression
among
patients
with
chronic
kidney
disease
(CKD)
have
not
been
thoroughly
explored.
This
study
aimed
to
explore
the
individual
vitamin
intakes
and
joint
effect
intake
multiple
vitamins
(including
A,
B
1
,
2
6
12
C,
D,
E,
K)
risk
in
participants
CKD.
Methods
A
total
3,123
CKD
(weighted
n
=
25,186,480)
from
National
Health
Nutrition
Examination
Survey
database
2007
2014
were
included.
Weighted
multivariate
logistic
regression
models
utilized
analyze
associations
dietary
risk.
Additionally,
Bayesian
kernel
machine
(BKMR)
weighted
quantile
sum
(WQS)
performed
evaluate
nine
Results
overall
prevalence
was
approximately
11.3%
participants.
In
fully
adjusted
model,
high
(OR:
0.54,
95%
CI:
0.40–0.74),
0.67,
0.48–0.95),
0.70,
0.49–0.99),
D
0.67.
0.48–0.94),
K
0.61,
0.44–0.85)
associated
a
reduced
likelihood
depression.
BKMR
WQS
showed
that
had
significant
negative
depression,
being
largest
contributor
two
models.
Lastly,
reflected
mixed
0.82,
0.69–0.99).
Conclusion
High
are
low
Furthermore,
co-exposure
is
crucial
factor
contributing
this
population.
Language: Английский
The global burden of chronic kidney disease due to glomerulonephritis: trends and predictions
Xiaotong Wang,
No information about this author
Zhaoyi Liu,
No information about this author
Yi Na
No information about this author
et al.
International Urology and Nephrology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 5, 2025
Glomerulonephritis
(GN),
one
of
the
primary
causes
chronic
kidney
disease
(CKD),
is
gaining
recognition
as
a
major
public
health
issue.
This
research
sought
to
evaluate
worldwide
impact
due
glomerulonephritis
(GN-CKD)
between
1990
and
2021
forecast
trends
up
2036,
leveraging
data
from
Global
Burden
Disease
(GBD)
study.
The
analysis
GN-CKD
utilized
GBD
open
secondary
dataset
examine
global
prevalence,
deaths,
disability-adjusted
life
years
(DALYs),
age-standardized
rates
GN-CKD,
changing
these
indicators
were
statistically
analyzed.
To
assess
practical
difference
each
country/region
frontier,
we
DALYs
Socio-Demographic
Index
(SDI).
assist
healthcare
institutions
in
formulating
more
effective
policies,
mortality
rate
until
2036
predicted
using
Bayesian
age-period-cohort
(BAPC)
modeling
techniques.
prevalence
indicated
by
(ASPR),
grew
10.81%
2021,
with
marginal
average
annual
change
0.04
(AAPC0.04,
0.03-0.05).
Similarly,
there
was
an
increase
15.84%
death
(ASDR)
for
during
this
period,
trend
0.50
(AAPC0.50,
0.41-0.59).
Moreover,
(ASYR)
observed
upward
8.60%
modest
0.27
(AAPC0.27,
0.17-0.37).
Our
findings
indicate
that
differs
across
gender,
geographic
areas,
socioeconomic
statuses.
Elevated
fasting
plasma
glucose
levels,
high
body-mass
index
(BMI),
elevated
systolic
blood
pressure
main
contributors
deaths
(DALYs).
Fortunately,
burden
expected
diminish
2036.
has
risen,
variations
genders
SDI
regions.
Encouraging
point
toward
potential
reduction
GN-CKD-related
future.
Language: Английский
Epidemiological trends and risk factors of CKD-T1DM in children and adolescents across 204 countries and territories (1990–2021)
Beiyan Liu,
No information about this author
Fengrui Li,
No information about this author
Huanxi Cui
No information about this author
et al.
Frontiers in Endocrinology,
Journal Year:
2025,
Volume and Issue:
16
Published: March 26, 2025
Background
Global
T1DM
incidence
in
children
and
adolescents
is
rising,
leading
to
Chronic
Kidney
Disease
due
Type
1
Diabetes
Mellitus
(CKD-T1DM),
a
critical
public
health
concern.
Severe
cases
evolve
into
end-stage
kidney
disease
(ESKD),
requiring
dialysis
or
transplantation,
severely
impacting
quality
of
life
imposing
substantial
burdens.
Methods
This
study
used
Burden
(GBD)
data
analyze
global
regional
CKD-T1DM
incidence,
prevalence,
mortality,
Disability-Adjusted
Life
Years
(DALYs)
rates
(1990-2021).
It
calculated
age-standardized
ratios
estimated
annual
percentage
change
(EAPC),
presenting
findings
via
maps
comparing
age-specific
burdens
mortality
patterns.
Findings
From
1990
2021,
prevalence
increased
globally,
while
DALYs
declined.
Middle
SDI
(Socio-Demographic
Index)
nations
saw
surge
new
cases,
contrasting
with
High
countries’
success
reducing
DALYs.
Male
were
higher
than
those
females,
notable
rises
Eastern
Europe,
Central
Latin
America,
drops
East
Asia.
The
10-14
age
group
exhibited
the
15-19
Interpretation
management
faces
challenges.
Future
research
should
focus
on
SDI-specific
needs,
resource
allocation,
awareness,
community
education.
Early
detection
comprehensive
protection
are
crucial,
especially
middle
low
countries
high-incidence
areas.
Language: Английский
Ramadan Fasting and Its Impact on Patients With Chronic Kidney Disease: Insights and Guidelines
Cureus,
Journal Year:
2024,
Volume and Issue:
unknown
Published: April 3, 2024
Fasting
during
the
month
of
Ramadan
is
a
religious
practice
observed
by
millions
Muslims
worldwide,
including
those
with
chronic
kidney
disease
(CKD).
This
comprehensive
review
aims
to
reflect
upon
impacts
fasting
on
CKD
patients,
excluding
renal
replacement
therapy,
through
an
analysis
clinical
trials,
observational
studies,
and
expert
reviews
from
diverse
geographic
methodological
backgrounds.
It
addresses
function
stability,
broader
health
considerations,
hydration
electrolyte
balance,
individual
variability
in
responses,
biochemical
effects,
nutritional
metabolic
effects.
reveals
that,
appropriate
monitoring,
dietary
management,
individualized
care
plans,
many
patients
can
safely
participate
without
adversely
affecting
their
or
overall
health.
emphasizes
need
for
multidisciplinary
approach
patient
education,
pre-Ramadan
assessment,
post-Ramadan
follow-up.
Furthermore,
it
highlights
importance
considering
comorbidities
guidance
underscores
necessity
future
research
develop
robust,
patient-centered
guidelines.
provide
healthcare
professionals
evidence-based
recommendations
support
wishing
observe
fasting,
ensuring
safety
optimizing
outcomes.
Language: Английский
Management of diabetes in people with advanced chronic kidney disease
Tahseen A Chowdhury,
No information about this author
Dorcas Mukuba,
No information about this author
Mahalia Casabar
No information about this author
et al.
Diabetic Medicine,
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 11, 2024
Abstract
Diabetes
is
the
commonest
cause
of
end
stage
kidney
disease
globally,
accounting
for
almost
40%
new
cases
requiring
renal
replacement
therapy.
Management
diabetes
in
people
with
advanced
on
therapy
challenging
due
to
some
unique
aspects
assessment
and
treatment
this
group
patients.
Standard
glycaemic
using
glycated
haemoglobin
may
not
be
valid
such
patients
altered
red
blood
cell
turnover
or
iron/erythropoietin
deficiency,
leading
changed
longevity.
Therefore,
use
continuous
glucose
monitoring
beneficial
enable
more
focussed
improved
adjustment
People
at
higher
risk
hypoglycaemia
a
number
physiological
mechanisms,
addition,
therapeutic
options
are
limited
lack
experience
license.
Insulin
basis
many
other
drugs
classes
being
contraindicated.
Targets
control
should
adjusted
according
co‐morbidity
frailty,
used
dialysis
ensure
low
hypoglycaemia.
Post‐transplant
common
amongst
undergoing
solid
organ
transplantation
confers
greater
mortality
morbidity
transplant
recipients.
It
actively
screened
managed
post‐transplant
setting.
Language: Английский
Artificial intelligence in predicting chronic kidney disease prognosis. A systematic review and meta-analysis
Qinyu Pan,
No information about this author
Mengli Tong
No information about this author
Renal Failure,
Journal Year:
2024,
Volume and Issue:
46(2)
Published: Dec. 11, 2024
Chronic
kidney
disease
(CKD)
is
a
common
condition
that
can
lead
to
serious
health
complications.
Artificial
Intelligence
(AI)
has
shown
the
potential
improve
prediction
of
CKD
progression,
offering
increased
accuracy
over
traditional
methods.
Therefore,
this
systematic
review
and
meta-analysis
examine
diagnostic
performance
various
AI
models
in
predicting
CKD.
Language: Английский